Deutsche Bank Initiates ProQR Therapeutics With Buy


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Analysts at Deutsche Bank initiated coverage on ProQR Therapeutics (NASDAQ: PRQR) with a Buy rating. The target price for ProQR Therapeutics is set to $32. ProQR Therapeutics' shares fell 4% to close at $12.48 yesterday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: InitiationAnalyst RatingsDeutsche Bank